V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007797 | 220020442 | 1.74 | null | Curative (C) | 2015-10-13 | 2015-10-13 | AML18 PILOT TRIAL | N | N | 220033159 | PILOT TRIAL |
| 220007798 | 220020442 | 1.68 | 56.5 | Not known (9) | 2014-03-23 | 2014-03-23 | Idarubicin+Tretinoin Spanish Crse4 | N | null | 220033159 | IDARUBICIN + TRETINOIN |
| 220007799 | 220003096 | 1.82 | 81.8 | null | null | 2013-09-05 | AML16 Low Dose Cytarabine | Y | N | 220033174 | AML16 TRIAL |
| 220007800 | 220011726 | 1.6 | null | Curative (C) | 2015-06-18 | 2015-06-18 | CARBOPLATIN + PACLITAXEL | 2 | N | 220033175 | CARBOPLATIN + PACLITAXEL |
| 220007801 | 220011726 | null | null | Palliative (P) | 2017-11-26 | 2017-12-09 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220033175 | CISPLATIN + GEMCITABINE |
| 220007802 | 220018935 | 1.7 | 95.5 | Palliative (P) | 2016-04-21 | 2016-05-02 | GemCarbo Days 1+8 | 2 | N | 220033179 | GEMCARBO |
| 220007803 | 220018935 | 1.86 | null | Palliative (P) | 2013-08-16 | 2013-08-22 | CARBOPLATIN + PACLITAXEL | N | N | 220033179 | CARBOPLATIN + PACLITAXEL |
| 220007804 | 220003097 | 1.61 | 106 | Disease modification (D) | null | 2014-12-26 | AML18 PILOT TRIAL | 1 | N | 220033188 | PILOT TRIAL |
| 220007805 | 220003097 | null | 77.6 | Curative (C) | 2014-02-13 | 2014-02-16 | Carboplatin + Paclitaxel (weekly) | null | N | 220033188 | CARBOPLATIN + PACLITAXEL |
| 220007806 | 220003097 | 1.5 | 47.2 | Curative (C) | 2015-03-23 | 2015-03-24 | IDARUBICIN + TRETINOIN | 02 | N | 220033188 | IDARUBICIN + TRETINOIN |
| 220007808 | 220003099 | null | 0 | Disease modification (D) | 2018-11-06 | 2018-11-09 | Dasatinib | 2 | N | 220033199 | DASATINIB |
| 220007809 | 220011728 | 1.64 | 76.9 | Curative (C) | 2016-05-20 | 2016-05-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 220033201 | CARBOPLATIN + PACLITAXEL |
| 220007810 | 220011728 | 1.94 | 84.9 | Curative (C) | 2013-08-06 | 2013-07-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220033201 | CARBOPLATIN + PACLITAXEL |
| 220007811 | 220018936 | 1.7 | 88 | null | 2015-10-03 | 2015-10-06 | GEMCARBO | 02 | N | 220033204 | GEMCARBO |
| 220007812 | 220018936 | 1.73 | 69.1 | null | 2015-08-21 | 2015-08-21 | CISPLATIN + GEMCITABINE | 02 | Y | 220033204 | CISPLATIN + GEMCITABINE |
| 220007813 | 220018936 | null | 77.5 | null | 2014-09-26 | 2014-09-26 | AML16 DA 3+10 | 02 | N | 220033204 | AML16 TRIAL |
| 220007814 | 220018936 | 163 | 58.4 | Curative (C) | 2013-06-08 | 2013-06-10 | AML16 DA 3+10 | N | N | 220033204 | AML16 TRIAL |
| 220007815 | 220018936 | 1.69 | 82.6 | Curative (C) | null | 2014-06-30 | Idarubicin+Tretinoin Spanish Crse2 | 02 | N | 220033204 | IDARUBICIN + TRETINOIN |
| 220007816 | 220003100 | 1.5 | 59 | Palliative (P) | 2014-06-13 | 2014-06-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220033217 | CISPLATIN + GEMCITABINE |
| 220007817 | 220003100 | 1.5 | 47.2 | Curative (C) | 2015-12-17 | 2015-12-18 | AML18 PILOT TRIAL | Y | null | 220033217 | PILOT TRIAL |
| 220007818 | 220003100 | 1.62 | 54.25 | Curative (C) | 2017-06-03 | 2017-06-03 | AML18 PILOT TRIAL | Y | N | 220033217 | PILOT TRIAL |
| 220007819 | 220003101 | 1.82 | 93 | Disease modification (D) | 2015-03-21 | 2015-03-25 | AML18 PILOT TRIAL | N | N | 220033222 | PILOT TRIAL |
| 220007820 | 220003101 | 1.78 | 99 | null | 2017-10-03 | 2017-10-03 | AML16 DA 3+8 | N | N | 220033222 | AML16 TRIAL |
| 220007821 | 220003102 | 1.79 | null | Disease modification (D) | 2016-09-06 | 2016-09-07 | AML 18 TRIAL | Y | N | 220033224 | AML18 TRIAL |
| 220007823 | 220003104 | null | 100.5 | null | 2013-06-06 | 2013-06-09 | GemCarbo Days 1+8 | 2 | null | 220033231 | GEMCARBO |
| 220007824 | 220003104 | 1.57 | 58.2 | Curative (C) | 2015-08-07 | 2015-08-07 | AML 18 Pilot Trial | N | N | 220033231 | PILOT TRIAL |
| 220007825 | 220003105 | 1.48 | 73 | Palliative (P) | 2014-05-21 | 2014-05-22 | GemCarbo Days 1+8 | N | N | 220033240 | GEMCARBO |
| 220007826 | 220003106 | 1.59 | null | null | 2017-08-26 | 2017-08-29 | AML 18 TRIAL | N | N | 220033242 | AML18 TRIAL |
| 220007827 | 220003107 | 1.57 | null | Palliative (P) | 2015-06-20 | 2015-06-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220033243 | CISPLATIN + GEMCITABINE |
| 220007828 | 220003108 | null | 76.2 | Neo-adjuvant (N) | null | 2015-09-19 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220033245 | CARBOPLATIN + PACLITAXEL |
| 220007829 | 220003108 | null | 73.5 | Palliative (P) | 2015-03-27 | 2015-04-30 | Carboplatin + Paclitaxel (weekly) | 2 | N | 220033245 | CARBOPLATIN + PACLITAXEL |
| 220007830 | 220003109 | 1.86 | null | Curative (C) | 2015-08-06 | 2015-08-06 | AML 18 TRIAL | Y | N | 220033250 | AML18 TRIAL |
| 220007831 | 220003110 | 1.73 | 82 | Curative (C) | 2013-04-17 | 2013-04-28 | AML18 PILOT TRIAL | N | null | 220033254 | PILOT TRIAL |
| 220007832 | 220003111 | 0 | 82.3 | Curative (C) | 2014-10-10 | 2014-10-10 | AML16 Azacitidine | Y | N | 220033256 | AML16 TRIAL |
| 220007833 | 220003111 | 1.77 | 119 | Curative (C) | 2014-05-17 | 2014-05-28 | AML 18 TRIAL | 1 | N | 220033256 | AML18 TRIAL |
| 220007834 | 220003112 | 1.5 | null | Curative (C) | 2017-02-28 | 2017-02-28 | AML16 Azacitidine | N | N | 220033259 | AML16 TRIAL |
| 220007835 | 220011734 | 1.86 | 0 | Curative (C) | 2016-01-01 | 2016-01-06 | AML16 Azacitidine | N | N | 220033260 | AML16 TRIAL |
| 220007836 | 220003113 | null | 94.6 | Disease modification (D) | 2016-03-23 | 2016-03-24 | AML 18 TRIAL | 01 | N | 220033262 | AML18 TRIAL |
| 220007837 | 220003114 | 1.54 | 117.4 | Palliative (P) | 2014-05-19 | 2014-06-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220033266 | CARBOPLATIN + PACLITAXEL |
| 220007838 | 220003115 | 0 | 87 | Curative (C) | null | 2017-07-24 | Idarubicin+Tretinoin Spanish Crse1 | 2 | N | 220033268 | IDARUBICIN + TRETINOIN |
| 220007839 | 220003116 | null | 47.5 | Palliative (P) | 2014-11-23 | 2014-12-12 | Dasatinib | null | N | 220033269 | DASATINIB |
| 220007840 | 220003117 | 1.78 | 78.1 | Curative (C) | 2017-11-30 | 2017-11-02 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220033272 | CARBOPLATIN + PACLITAXEL |
| 220007843 | 220003119 | 1.71 | 61.5 | Palliative (P) | 2015-01-14 | 2015-01-20 | Carboplatin + Etoposide iv&po | null | null | 220033279 | CARBOPLATIN + ETOPOSIDE |
| 220007844 | 220003120 | 0 | 75.6 | Palliative (P) | 2017-04-13 | 2017-05-03 | EOX | 2 | N | 220033281 | EOX |
| 220007845 | 220003121 | 1.7 | 101 | Neo-adjuvant (N) | 2016-12-01 | 2016-12-15 | ECX | null | null | 220033283 | ECX |
| 220007846 | 220003121 | null | 63 | Palliative (P) | 2016-01-11 | 2016-01-13 | Rituximab | N | N | 220033283 | RAVVA TRIAL |
| 220007847 | 220003122 | 1.57 | 78.2 | Palliative (P) | 2014-02-27 | 2014-02-28 | Carboplatin + Etoposide iv&po | N | N | 220033286 | CARBOPLATIN + ETOPOSIDE |
| 220007848 | 220003122 | null | 99.5 | Curative (C) | 2013-08-22 | 2013-08-22 | ADE 10+3+5 | N | null | 220033286 | ADE |
| 220007849 | 220003122 | 1.58 | 68 | Curative (C) | 2016-02-22 | 2016-02-22 | AML Int Guide ADE 10+3+5 (1) | N | N | 220033286 | ADE |
| 220007850 | 220003122 | 1.53 | 99.2 | Palliative (P) | 2015-10-23 | 2015-10-25 | Gemcitabine weekly | N | N | 220033286 | PEMBROLIZUMAB |